B. Téhard

2.9k total citations
28 papers, 799 citations indexed

About

B. Téhard is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, B. Téhard has authored 28 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Economics and Econometrics. Recurrent topics in B. Téhard's work include Hepatitis Viruses Studies and Epidemiology (6 papers), Cancer Risks and Factors (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). B. Téhard is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (6 papers), Cancer Risks and Factors (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). B. Téhard collaborates with scholars based in France, United Kingdom and Belgium. B. Téhard's co-authors include Françoise Clavel‐Chapelon, Marti van Liere, F Clavel-Chapelon, Jean‐Michel Oppert, Christine M. Friedenreich, Teresa Norat, Y. Mallet, Serge Herçberg, Paule Latino‐Martel and Nathalie Druesne‐Pecollo and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and Medicine & Science in Sports & Exercise.

In The Last Decade

B. Téhard

28 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Téhard France	14	281	234	149	148	111	28	799
Caroline E. Boeke United States	18	228 0.8×	253 1.1×	241 1.6×	135 0.9×	39 0.4×	41	1.2k
Van Dinh Tran Australia	18	283 1.0×	96 0.4×	193 1.3×	92 0.6×	56 0.5×	54	918
Tarek Turk Syria	16	179 0.6×	115 0.5×	99 0.7×	46 0.3×	48 0.4×	49	1.0k
Patravoot Vatanasapt Thailand	22	348 1.2×	75 0.3×	170 1.1×	81 0.5×	75 0.7×	72	1.2k
Safoora Gharibzadeh Iran	19	55 0.2×	138 0.6×	145 1.0×	161 1.1×	79 0.7×	84	914
Krzysztof Czajkowski Poland	16	93 0.3×	305 1.3×	173 1.2×	48 0.3×	26 0.2×	138	1.1k
Adam J. Esbenshade United States	17	242 0.9×	225 1.0×	175 1.2×	37 0.3×	48 0.4×	60	866
Cüneyt Eftal Taner Türkiye	20	106 0.4×	316 1.4×	202 1.4×	81 0.5×	45 0.4×	83	1.1k
Nancy Russell United States	14	207 0.7×	223 1.0×	59 0.4×	43 0.3×	26 0.2×	17	774
Mindy Ginsberg United States	15	268 1.0×	219 0.9×	59 0.4×	97 0.7×	178 1.6×	48	902

Countries citing papers authored by B. Téhard

Since Specialization

Citations

This map shows the geographic impact of B. Téhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Téhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Téhard more than expected).

Fields of papers citing papers by B. Téhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Téhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Téhard. The network helps show where B. Téhard may publish in the future.

Co-authorship network of co-authors of B. Téhard

This figure shows the co-authorship network connecting the top 25 collaborators of B. Téhard. A scholar is included among the top collaborators of B. Téhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Téhard. B. Téhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Téhard, B., et al.. (2020). Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France. PLoS ONE. 15(1). e0226196–e0226196. 16 indexed citations

Petitjean, Audrey, Jayne Smith‐Palmer, William J. Valentine, B. Téhard, & Stéphane Roze. (2019). Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France. BMC Cancer. 19(1). 140–140. 8 indexed citations

Téhard, B., et al.. (2019). PRO122 ECONOMIC EVALUATION OF NUSINERSEN IN SPINAL MUSCULAR ATROPHY: A COMPARISON OF NICE AND HAS OPINIONS. Value in Health. 22. S863–S864. 1 indexed citations

Téhard, B., et al.. (2019). PCN122 COST-EFFECTIVENESS ANALYSIS OF TRASUTUZUMAB EMTANSINE VERSUS TRASTUZUMAB FOR WOMEN WITH HER2+ ADJUVANT BREAST CANCER IN FRANCE. Value in Health. 22. S459–S459. 1 indexed citations

Girard, Nicolas, et al.. (2018). Extra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis. ESMO Open. 3(6). e000414–e000414. 15 indexed citations

Coudert, Bruno, Paul Cottu, David Pérol, et al.. (2017). The Personalised Reimbursement Models (Prm): Real World Data Collection to Provide Innovative Pricing Solutions in France. Value in Health. 20(9). A743–A743. 1 indexed citations

Ray‐Coquard, Isabelle, Olivier Collard, Françoise Ducimetière, et al.. (2017). Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS). BMC Cancer. 17(1). 111–111. 10 indexed citations

Sage, F. Vié le, J. Gaudelus, F. Lert, et al.. (2016). Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants’ vaccination against hepatitis B in general and pediatric practices – the PRALINE study. Revue d Épidémiologie et de Santé Publique. 64(3). 185–194. 4 indexed citations

Gaudelus, J., F. Vié le Sage, Véronique Dufour, et al.. (2015). Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population – the PopCorn study. Revue d Épidémiologie et de Santé Publique. 64(1). 23–32. 4 indexed citations

10.

Tilleul, P., et al.. (2015). Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective. Value in Health. 18(7). A373–A373. 1 indexed citations

11.

Ouwens, Mario, Kavi J. Littlewood, Christophe Sauboin, et al.. (2015). The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella Vaccination in France on the Epidemiology of Varicella and Zoster Using a Dynamic Model With an Empirical Contact Matrix. Clinical Therapeutics. 37(4). 816–829.e10. 15 indexed citations

12.

Parez, N., et al.. (2012). Incidence des gastroentérites à rotavirus chez les enfants de moins de cinq ans consultant un pédiatre ou un médecin généraliste en France. Pathologie Biologie. 61(3). 99–107. 5 indexed citations

13.

Parez, N., et al.. (2011). Impact des gastroentérites à Rotavirus chez les enfants de moins de cinq ans hospitalisés ou consultant en services d’urgences en France. Pathologie Biologie. 60(5). 275–281. 3 indexed citations

14.

Demarteau, Nadia, B. Detournay, B. Téhard, Abdelkader El Hasnaoui, & Baudouin Standaert. (2010). A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer. International Journal of Public Health. 56(2). 153–162. 25 indexed citations

15.

Druesne‐Pecollo, Nathalie, B. Téhard, Y. Mallet, et al.. (2009). Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. The Lancet Oncology. 10(2). 173–180. 171 indexed citations

16.

Téhard, B., et al.. (2005). Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. International Journal of Obesity. 30(1). 156–163. 67 indexed citations

17.

Téhard, B., Rudolf Kaaks, & F. Clavel-Chapelon. (2005). Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study. British Journal of Cancer. 92(11). 2042–2048. 14 indexed citations

18.

Téhard, B., Wim H. M. Saris, Arne Astrup, et al.. (2005). Comparison of Two Physical Activity Questionnaires in Obese Subjects: The NUGENOB Study. Medicine & Science in Sports & Exercise. 37(9). 1535–1541. 65 indexed citations

19.

Téhard, B., Petra H. Lahmann, Elio Ríboli, & Françoise Clavel‐Chapelon. (2004). Anthropometry, breast cancer and menopausal status: Use of repeated measurements over 10 years of follow‐up—results of the French E3N women's cohort study. International Journal of Cancer. 111(2). 264–269. 27 indexed citations

20.

Reinberg, Olivier, Alain Reinberg, B. Téhard, & Mohamed Mechkouri. (2002). Accidents in children do not happen at random: Predictable time-of-day incidence of childhood trauma. Chronobiology International. 19(3). 615–631. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact